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Summary 
Graft-versus-host disease (GVHD) is the main complication after allogeneic bone marrow 
transplantation. Although the tissue damage and subsequent patient mortality are clearly depen- 
dent on T lymphocytes present in the grafted inoculum, the lethal effector molecules are un- 
known. Here, we show that acute lethal GVHD, induced by the transfer of splenocytes from 
C57BL/6 mice into sensitive BALB/c recipients, is dependent on both perforin and Fas ligand 
(FasL)-mediated lytic pathways. When spleen cells from mutant mice lacking both effector 
molecules were transferred to sublethally irradiated allogeneic recipients, mice survived. De- 
layed mortality was observed with grafted cells deficient in only one lytic mediator. In contrast, 
protection from lethal acute GVHD in resistant mice was exclusively pefforin dependent. Per- 
forin-FasL-deficient T cells failed to lyse most target cells in vitro. However, they still effi- 
ciently killed tumor necrosis factor oe-sensitive fibroblasts, demonstrating that cytotoxic T cells 
possess a third lytic pathway. 
C TL are important cytolytic effector cells of the im- mune defense system against viruses and tumors (1). 
CD4 + and CD8 + CTL are also involved in autoimmunity 
and transplant rejection. The recent development of mice 
in which the gene for perforin is disrupted (2-4) has pro- 
vided evidence for the existence of two separate lytic path- 
ways: first, the formation of membrane pores by perforin 
released from intracellular stores (5) followed by the pro- 
teolytic action of granzymes that are coreleased with per- 
forin and that induce apoptosis in the target cell (6); sec- 
ond, the triggering of the Fas (Apo-1)-induced apoptotic 
pathway by Fas ligand (FasL) exposed on the CTL surface 
(7). At present it appears that the two pathways account for 
all cytolytic activity of CTL. However, only a restricted 
number of target cells could be analyzed, since functional 
inactivation of the Fas pathway is achieved by the use of 
target cells from lpr mice, which express little or no Fas (8). 
Thus, it cannot be excluded that other lytic molecules uch 
as TNF-r which is detected on the surface of activated T
lymphocytes (9), contribute to the cytotoxicity of CTU 
For this reason we generated mice in which both perforin 
and FasL are nonfunctional, by crossing perforin knock-out 
mice with gld mice, which bear a mutation in the FasL 
gene leading to its functional inactivation (10). Our study 
The first wo authors contributed qually to this work. 
now shows that CTL derived from these mice still display 
lytic activity on transformed fibroblast cell lines. 
These double-mutant mice also offered the unique pos- 
sibility to evaluate the role ofperforin and FasL in GVHD. 
GVHD continues to be a major complication after alloge- 
neic bone marrow transplantation (BMT) (11). An acute 
lethal form of GVHD is caused by activation of the host- 
reactive donor effector T cells (12). The major organs af- 
fected in GVHD are skin, liver, intestine, and lymphoid tis- 
sues (13, 14), and symptoms range from varying degrees of 
erythroderma, wasting, diarrhea, splenomegaly, and lymph- 
adenopathy to death (14). The lytic mechanisms leading to 
lesion formation are only poorly understood and might in- 
volve, for acute GVHD, direct interactions between donor 
CTL and host target cells, or more indirect mechanisms 
mediated by interleukins released by the donor T cells (15). 
We therefore xplored the possibility that perforin or FasL 
may play a role in the etiology of the lesions seen in 
GVHD. 
Mater ia ls  and  Methods  
Animals. Pefforin-deficient (P-/-) gld/gld mice were gener- 
ated by crossing pefforin knock-out (C57BL/6 • 129)F3 mice 
(16) with C57BL/6 gld/gld mice (The Jackson Laboratory, Bar 
Harbor, ME) and by subsequent intercrossing of heterozygous F1 
animals. To detect he FasL-gld mutation, mouse tail DNA was 
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PCR amplified using the following primers: 5'-CACTCAAG- 
GTCCATCCCTCTG-3' and 5'-ATATTCCTGGTGCCCAT- 
GAT-3'. The amplification product was sequenced to detect he 
gld homozygotes (17, 18). Mice were screened for the defective 
perforin gene as described (16) . 
Flow Cytometric Analysis. Splenocytes from 6- and 16-wk-old 
mice were isolated and freed from red blood cells by 15-min in- 
cubation in an ice cold buffer containing 13 mM sodium bicar- 
bonate, 156 m/vl ammonium chloride, and 127 I~M EDTA, and 
then resuspended in PBS supplemented with 5% FCS and 0.02% 
NaN 3. Splenocytes were stained with Tri-Color-conjugated anti- 
B220 antibodies and HTC-labeled anti-CD3 antibodies (CAL- 
TAG Laboratories, South San Francisco, CA) and analyzed using 
a FACScan | flow cytometer (Becton Dickinson Immunocyto- 
metric Systems, Mountain View, CA) using the Lysis II software. 
Cytolytic Assays. Alloreactive cytotoxic T lymphocytes were 
generated in a 5-d mixed lymphocyte culture (16). Responder 
spleen cells (2.5 • 106/m1-1) were from adult 6-wk-old mice de- 
ficient for pefforin, functional FasL (gld/gld), or both. All mice 
were of H-2 b haplotype. Stimulators were irradiated spleen cells 
(2.5 • 106/ml -l, 3,000 rad) from either DBA/2 mice (H-2 d) or 
C3H (H-2 k) mice. Target ceils were activated splenocytes from 
DBA/2 mice stimulated with ConA (4 pLg/m1-1) for 3 d (2), 
A20.2J B cell lymphomas (H-2a), WEHI 164 fibrosarcomas 
(H-2a), and L929 (H-2 k) fibrosarcomas, allobtained from Ameri- 
can Type Culture Collection (Rockviile, MD). Mouse embry- 
onic fibroblasts (MEF) were isolated from 12 to 14-d-old C3H 
embryos as described (2). Cytotoxicity on targets of hematopoi- 
etic origin was assayed after 4 h for SlCr release and DNA degra- 
dation (16). Adherent target cells were labeled with SiCr for 12 h 
as described elsewhere (16), and SlCr release was determined after 
a 20-h incubation. Recombinant mouse TNF-ot was obtained 
from Dr. J. Browning, Biogen (Boston, MA). 
Induction of G VHD. 6-wk-old female recipients were given a 
sublethal dose of Co irradiation (5 Gy; 1.2 Gy/min). Within 1 h, 
40 • 106 of spleen cells isolated from female allogeneic donors 
were injected through the tail vein. Animals used in the study 
were BALB/c, C57BL/6, 129, (C57BL/6 • 129)F1, (C57BL/6 • 
129)P - / - ,  C57BL/6 gld/gld, and (C57BL/6 X 129)p-l-girl~girl 
mice. R.ate of survival was recorded aily. Mice with the gld/gld 
mutation were used at 5-6 wk of age. A minimum of four recip- 
ient animals were used in each experimental group. 
Results and Discussion 
Mutant mice deficient for both perforin and functional 
FasL were generated by intercrossing P - / -  mice (16) with 
gld/gld mice (19) lacking functional FasL (17, 18). Animals 
homozygous for both nonfunctional genes were viable. 
Flow immunocytometric analysis of  the spleen cell popula- 
tion of  young animals (6 wk old) showed a phenotype sim- 
ilar to that observed in normal mice (Fig. 1). With progres- 
sive age (from 8 wk old onward), however, these mice 
developed a more severe lymphadenopathy than the one 
previously described in gld/gld mice (19). Lymphoid organs 
of  P-/-gld/gld mice were massively enlarged. Spleens de- 
rived from 16-wk-old P-/-gld/gld mice were on average 
seven times heavier than those from age-matched P - / -  
mice, or 3.5 times heavier than the corresponding organs 
from gld/gld mice (Lowin, B., and J. Tschopp, unpublished 
results). A predominant CD3+B220+CD4-CD8 - popula- 
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Figure 1. Lymphocyte populations in the spleen of P-/-, girl~girl, and 
P-/-gld/gld mice. Spleen cells were analyzed for the expression of CD3 
and B220 by flow cytometry. Normal development of splenocytes de- 
rived from 6-wk-old P-/-gld/gld nfice and accumulation of CD3 +B220 + 
cells in splenocytes from 16-wk-old P-/-gld/gld and gld/gld mice. The 
CD3+B220 + population was CD4-CD8- (data not shown). 
tion accumulated (Fig. 1) that resembled the T cell popula- 
tion found in gld/gld mice (19). This phenotype represented 
~50% of all splenocytes in 16-wk-old double-mutant mice 
(Fig. 1). A high proportion of  T cells in P-/-gld/gld mice 
expressed activation markers such as CD69 (data not 
shown), pointing to a chronic activation of  the immune 
system. Most mice died at an age of  4-5 mo. 
T cells from double mutant animals exhibited no lytic 
activity on several target cells tested. Whereas alloreactive 
T cells (H-2 b) derived from 6-wk-old P - / -  and gld/gld 
mice were able to kill ConA-stimulated allogeneic lym- 
phoid cells (H-2 d) as well as the B cell lymphoma A20, 
splenocytes from P-/-gld/gld mice were completely inac- 
tive (Fig. 2). The differences in cytotoxicity are unlikely to 
be caused by large differences in the allogeneic reaction, 
since IFN-~/ concentration i  the supernatants of  the re- 
spective mixed leukocyte reactions was similar (3,000 + 
500 U/n i l  supematant). These data thus confirm that per- 
forin- and Fas-dependent pathways are responsible for all 
detectable lytic activity against lymphoid targets in short 
term cytotoxicity assays (2-4, 20). Cytolytic activity was 
also tested in long-term (20 h) cytotoxicity assays against 
nonhematopoietic target cells, that is, the fibrosarcoma 
WEHI -164 (H-2a), L929 (H-2k), and MEF (H-2a). As 
shown in Fig. 3 a, MEF cells were not lysed in the absence 
658 Role ofFas Ligand and Perforin in GVHD 
:~ i~ 
20 
~' 20 1 
o -  o , 
~" 10 30 3 10 30 
E : T ratio E : T ratio 
Figure 2. Killing of hematopoietic target cells by P-/-gld/gld CTL. 
CTL activity o fMHC alloantigen-specific T ells (H-2 b anti-H-2 a) from 
normal mice (triangles), P- / -  mice (squares), gld/gld mice (drcles) and P-/-gld/ 
~ld mice (diamonds) was tested on ConA-activated spleen cells [filled sym- 
bols) and on the B cell lymphoma A20 (open symbols). The lytic activity 
was determined in both standard S:Cr release (left) and DNA degradation 
(right) assays. 
of both perforin and functional FasL, but surprisingly, kill- 
ing of WEHI-164 and L929 was not significantly affected. 
The sensitivity pattern of target cells correlated with their 
respective susceptibility to TNF-~t (Fig. 3 b), a cytokine 
mainly secreted by activated macrophages, NK cells, and 
some subpopularions o f t  cells (9). TNF-tx has been shown 
in vitro to exhibit slow cytolytic activity (21), and in vivo, 
the production of TNF-ot has been correlated with tissue 
injuries occurring in many immunopathological situations 
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F igure  3. Killing ofnonhematopoietic target cells by P-/-gld/gld CTL. 
(a) As in Fig. 2, alloantigen-specific T cells (H-26 anti-H-2 '~ and H-2 b 
anti-H-2 k) were generated in a 5-d mixed lymphocyte culture (P-/- 
[squares], gld/gld [circles], P-/-gld/gld [diamonds]), and their lytic activity 
was tested on the fibrosarcomas WEHI-164 (H-2 d, open symbols) and L929 
(H-2 k, filled symbols, left), and on primary MEF (H-2 k, right). (b) TNF-ot 
sensitivity of the same target cells as in (a) was determined in a 20-h cyto- 
toxicity test in the presence of increasing amounts of recombinant mouse 
TNF-ot (WEHI-164 [squares], L929 [circles], MEF [triangles]). 
(22-24). This suggests that TNF-ot-mediated cytotoxicity 
is at least in part responsible for the lyric activity remaining 
in P-/-  and FasL-deficient animals. Other cytolyric mole- 
cules, such as lymphotoxins (9) or NK lysins (25), may also 
contribute to the residual cytotoxicity, since neutralizing 
anti-TNF-ot antibodies only partially inhibited this activity 
(10-30% specific reduction). 
GVHD remains the main complication after allogeneic 
BMT. Since the effector molecules leading to lesion forma- 
tion are only poorly understood, we investigated the role 
of perforin- and Fas-mediated cytolytic pathways in a mu- 
rine model of acute lethal GVHD whereby donor spleno- 
cytes from C57BL/6 or 129 (H-2 b) mice are injected into 
sublethally irradiated allogeneic BALB/c (H-2 a) mice (26). 
Fig. 4 a shows that all BALB/c recipients injected with 
C57BL/6 or 129 spleen cells (40 X 106) died within 7 d, 
whereas injection of spleen cells from P-/-  mice or func- 
tional FasL-deficient mice delayed the onset of the disease 
(survival mean 17 and 24 d, respectively). In contrast, mice 
given cells from P-/-gld/gld animals were unaffected and 
survived (survival mean >50 d). 
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Figure 4. (a) Both perforin- and Fas-mediated cytotoxic pathways par- 
ticipate in lethal acute GVHD. Spleen cells from normal C57BL/6, 129, 
(C57BL/6 X 129)F1 donors, P - / -  and functional FasL-deficient mice 
(gld/gld) were transferred into sublethally irradiated BALB/c recipients, 
and the rate of mortality of the recipients was recorded. Animals given 
only sublethal irradiation survived indefinitely (survival mean >50 d). 
Data are representative of three experiments with at least four mice per 
group (including control donors) per experiment. (b) Resistance to lethal 
acute GVHD is perforin dependent. Normal BALB/c spleen cells were 
injected into sublethally irradiated normal [C57BL/6, 129, (C57BL/6 X 
129)F1], P- / - ,  orgld/gld recipients. 
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Whereas sublethally irradiated BALB/c mice die within 
7 d when inoculated with normal C57BL/6 spleen cells 
(Fig. 4 a), irradiated C57BL/6 (or 129) recipients injected 
with the same number of BALB/c spleen cells survive and 
show no signs of illness (Fig. 4 b) (26, 27). Whether this 
difference of sensitivity reflects the ability of the C57BL/6 
mice to eliminate potentially alloreactive BALB/c CTL 
from the graft or is caused by a low frequency of BALB/c 
anti-C57BL/6 CTL precursors in BALB/c splenocytes is 
not known. We therefore transferred normal BALB/c 
spleen cells into sublethally irradiated C57BL/6 recipients 
deficient for either perforin or functional FasL. BALB/c 
splenocytes failed to induce any symptoms of lethal GVHD 
in nomaal and gld/gld recipients (Fig. 4 b). In contrast, 
C57BL/6 recipients lacking functional perforin became 
susceptible to BALB/c splenocytes and died within 7-8 d. 
Thus, normal sublethally irradiated C57BL/6 recipients 
contain radioresistant cells that are able to suppress the ef- 
fector function of BALB/c splenocytes olely through a 
pefforin-dependent pathway. The cell population responsi- 
ble for this inhibition might include host antidonor ra- 
dioresistant CTL, NK  cells, or natural suppressor cells ap- 
pearing after total body irradiation (27, 28). 
In the murine model of lethal GVHD studied here, both 
perforin and FasL appear to play a crucial role in mortality. 
Other lytic effector molecules still detected in perforin- 
FasL-deficient lymphocytes contribute little, although our 
study cannot exclude the involvement of TNF-0~ or other 
cytokines in milder forms of GVHD,  as suggested by others 
(15, 23). In vivo, pefforin's implication in the clearance of 
lymphocytic boriomeningitis virus infection and fibrosar- 
coma tumor cells is well established (4, 29), whereas the Fas 
system was shown to be involved in the elimination of acti- 
vated lymphocytes in the periphery (7, 30). This study now 
demonstrates that FasL also participates in pathological tis- 
sue damage during GVHD,  in agreement with the observa- 
tion that injection of anti-Fas antibodies into adult mice 
can cause rapid death due to liver failure (31). In view of 
the massive upregulation of FasL in functional Fas recep- 
tor-lacking Ipr (lymphoproliferation) mice (32, 33), the se- 
vere wasting syndrome (GVHD) observed when lpr bone 
marrow-derived cells are adoptively transferred into a syn- 
geneic wild-type recipient (34) may also be explained. Tis- 
sues attacked in FasL-mediated GVHD probably include 
those that abundantly express Fas, such as liver, lung, or 
heart, whereas pefforin, with no requirement for a specific 
receptor (35), may eventually destroy any organ. 
Although both perforin- and Fas-dependent pathways 
are responsible for the mortality caused by acute GVHD in 
BALB/c mice, perforin-mediated cytotoxicity appears to 
be the only pathway required for the rejection ofallogeneic 
spleen cells. P - / -  mice still reject heart allografts (36), and 
thus effector mechanisms used to reject tissues and organs 
of different origin seem to differ. 
GVHD remains a major barrier to a wider application of 
allogeneic BMT for a variety of diseases. Provided that the 
active role of FasL and pefforin in the progression of acute 
GVHD can be illustrated in humans, the development of 
therapeutic strategies aimed at controlling the two cytolytic 
pathways during BMT may be an approach for decreasing 
the risk of GVHD.  
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